Want to track HYPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Zacks | 2 years ago
Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software
Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software.
Zacks | 2 years ago
Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop
Hyperfine (HYPR) is set to release study data in August 2024, showing the value of the Swoop system in enabling critical stroke treatment choices in urgent care settings.
Zacks | 2 years ago
Hyperfine (HYPR) Inks New Partnerships to Expand in Europe
Hyperfine (HYPR) announces that it has signed agreements with experienced and accomplished distributors in Germany, Austria, Switzerland, and key Nordic markets for its Swoop, a portable MRI system.
Zacks | 2 years ago
